Latest current cash for BDR: $79K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Blonder Tongue Laboratories's current cash stands at $79K as of December 2022. That compares with $270K in the prior-year period — down 71.2% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Blonder Tongue Laboratories reported $79K in current cash versus $270K a year earlier — a 71.2% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
That compares with $270K in the prior-year period — down 71.2% year over year. Sustained growth in current cash can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.
The history chart shows how Blonder Tongue Laboratories's current cash evolved across reporting periods, while the comparison chart places BDR next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Technology, current cash is commonly used to spot outliers. Blonder Tongue Laboratories's reading of $79K is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.